Identification of potential inhibitors of HER2 targeting breast cancer—a structure-based drug design approach

Author:

Singh Gagandeep12ORCID,Al-Fahad Dhurgham3,Al-Zrkani Mrtatha K.4ORCID,Chaudhuri Tapan K.2,Soni Hemant1,Tandon Smriti1,Narasimhaji Cheemalapati Venkata1,Azam Faizul5ORCID,Patil Rajesh6

Affiliation:

1. Section of Microbiology and Chemistry, Central Ayurveda Research Institute Jhansi, CCRAS, Ministry of Ayush, India

2. Kusuma School of Biological Sciences, Indian Institute of Technology Delhi, New Delhi, India

3. Department of Pharmaceutical Sciences, College of Pharmacy, University of Thi-Qar, Nasiriyah, Iraq

4. Department of Animal Production, College of Agriculture, Wasit University, Wasit, Iraq

5. Department of Pharmaceutical Chemistry and Pharmacognosy, Unaizah College of Pharmacy, Qassim University, Buraydah, Saudi Arabia

6. Department of Pharmaceutical Chemistry, Sinhgad Technical Education Society’s, Sinhgad College of Pharmacy, Pune, India

Publisher

Informa UK Limited

Subject

Molecular Biology,General Medicine,Structural Biology

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3